32 Participants Needed

Cervical Preparation for Abortion

AM
AM
Overseen ByAlana Martinusen, MPH
Age: Any Age
Sex: Female
Trial Phase: Academic
Sponsor: Boston Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This is a noninferiority randomized control trial of two cervical preparation methods prior to same-day Dilation \& Evacuation (D\&E). Cervical preparation is a process that softens and dilates the cervix prior to a procedure. The primary objective is to evidence noninferiority of cervical preparation using a single-balloon catheter method when compared to a group receiving osmotic dilators, specifically in D\&E operative time. Secondary objectives will compare the two methods for adequate dilation, ability to complete the operation in the same day, participant pain, satisfaction and safety.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment using synthetic osmotic dilators and a transcervical single-balloon catheter for cervical preparation for abortion?

Research shows that synthetic osmotic dilators are effective for softening and opening the cervix before surgical abortion, similar to other methods like laminaria tents. They can be used on the same day as the procedure, which may increase access to early second-trimester abortions.12345

Is cervical preparation with synthetic osmotic dilators safe for humans?

Research shows that synthetic osmotic dilators are generally safe for cervical preparation before surgical abortion. They may cause some discomfort but do not pose a substantial risk of magnesium toxicity and can reduce the risk of infection and cervical injury compared to not using any device.12346

How is the treatment with synthetic osmotic dilators and a transcervical single-balloon catheter different from other treatments for cervical preparation before abortion?

This treatment is unique because it uses synthetic osmotic dilators, which can be used on the same day as the procedure, potentially increasing access to early second-trimester surgical abortions. Unlike some other methods that require overnight preparation, this approach may offer a more convenient and less time-consuming option for cervical preparation.12347

Research Team

AM

Anjanique Mariquit Lu, MD

Principal Investigator

Boston Medical Center, Obstetrics and Gynecology

Eligibility Criteria

This trial is for individuals requiring cervical preparation before a same-day Dilation & Evacuation (D&E) procedure. Specific eligibility criteria are not provided, but typically participants would be those who need the procedure and meet certain health standards set by the study.

Inclusion Criteria

Between 16 weeks 0 days - 18 weeks 6 days gestational age who are pursuing termination, based on reliable gestational age (defined as ultrasonography performed by a clinical provider, or a certain last menstrual period)
Able to provide informed consent
Singleton intrauterine pregnancy

Exclusion Criteria

Incarceration or other inability to give informed consent
My BMI is over 45.
Allergy to betadine, aquacryl hydrogel, latex-free silicone single-balloon catheter, synthetic or natural osmotic dilators
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Cervical Preparation

Participants undergo cervical preparation using either a single-balloon catheter or osmotic dilators prior to Dilation & Evacuation (D&E)

Same day
1 visit (in-person)

Dilation & Evacuation (D&E) Procedure

Participants undergo the D&E procedure following cervical preparation

Approximately 20 minutes
1 visit (in-person)

Follow-up

Participants are monitored for safety, pain, and satisfaction after the procedure

3 hours post-procedure

Treatment Details

Interventions

  • Synthetic osmotic dilators
  • Transcervical single-balloon catheter
Trial Overview The trial is testing two methods of cervical preparation: synthetic osmotic dilators versus a transcervical single-balloon catheter. It aims to show that the balloon method is not worse than dilators in terms of operation time, dilation adequacy, ability to complete same-day surgery, pain levels, satisfaction, and safety.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Transcervical single-balloon catheter groupExperimental Treatment1 Intervention
Participants randomized to this arm will have cervical dilation done using a transcervical single-balloon catheter.
Group II: Osmotic dilators groupActive Control1 Intervention
Participants randomized to this arm will have cervical dilation done using osmotic dilators.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Boston Medical Center

Lead Sponsor

Trials
410
Recruited
890,000+

References

Mifepristone and misoprostol compared to osmotic dilators for cervical preparation prior to surgical abortion at 15-18 weeks' gestation: a randomised controlled non-inferiority trial. [2019]
Two cervical preparation regimens prior to surgical abortion at 10-14 weeks of gestation: A randomized clinical trial. [2018]
Cervical dilation from laminaria tents and synthetic osmotic dilators used for 6 hours before abortion. [2009]
Same-day synthetic osmotic dilators compared with overnight laminaria before abortion at 14-18 weeks of gestation: a randomized controlled trial. [2021]
The use of laminarias for osmotic dilation of the cervix in gynecological brachytherapy applications. [2019]
Use of osmotic dilators to facilitate induced midtrimester abortion: clinical evaluations. [2019]
Cervical preparation for first trimester surgical abortion. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security